These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nephrotic syndrome: Efficacy of rituximab in challenging nephrotic syndrome.
    Author: Lemley KV, Mak RH.
    Journal: Nat Rev Nephrol; 2015 May; 11(5):257-8. PubMed ID: 25752834.
    Abstract:
    A new trial provides further evidence that rituximab treatment can reduce the risk of relapse in children with steroid-dependent idiopathic nephrotic syndrome. Addition of a single infusion of rituximab to steroid therapy was associated with a decrease in proteinuria at 3 months and a significant increase in the relapse-free period.
    [Abstract] [Full Text] [Related] [New Search]